Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acurx Pharmaceuticals, Inc.

NASDAQ: ACXP · Life Sciences · 3 alerts · CIK 1736243

Share price
$0.9350Close, Nov 16
Market cap
$5.66M
Shares outstanding
6.06MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acurx Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:32 PM ET 8-K
Leadership Change

Acurx Pharmaceuticals Leadership Change

Joseph C. Scodari, a member of the Board of Directors since 2021, notified Acurx Pharmaceuticals of his intention to retire from the Board effective November 13, 2026. His departure is not due to any disagreement with the company, and he has agreed to continue serving as a corporate advisor following his retirement.

6:46 AM ET 10-Q
Financial Results

Acurx Pharmaceuticals Q3 2026 Results: Net Loss of $2.58M, Loss Widens

Acurx Pharmaceuticals reported a net loss of $6.5 million for the nine months ended September 30, 2026, compared to $6.4 million in the prior year period. The company strengthened its cash position to $9.7 million following equity issuances, while research and development expenses increased significantly in the third quarter to $1.1 million.

Key figure
Net loss $2.58M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.